SCHEMBL4426488

SCHEMBL4426488

C=CCC(c1ccccc1)P(=O)(OCC)OCC

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.55
MAPT P10636 3/20 0.51
ALDH1A1 P00352 1/20 0.51
LMNA P02545 1/20 0.51
KDM4E B2RXH2 1/20 0.45
NPSR1 Q6W5P4 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP2C19 P33261 1/20 0.42
MAPK1 P28482 2/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GAA P10253 1/20 0.40
NR1I2 O75469 1/20 0.40
KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4429348 0.86 CA12 (0.42) POLBMAPTALDH1A1LMNAKDM4E
SCHEMBL14520500 0.86 POLB (0.57) POLBMAPTALDH1A1LMNAKDM4E
SCHEMBL1837398 0.82 POLB (0.64) POLBMAPTALDH1A1LMNAKDM4E
SCHEMBL3291457 0.78 POLB (0.58) POLBMAPTALDH1A1LMNAKDM4E
SCHEMBL8352708 0.75 POLB (0.59) POLBMAPTALDH1A1LMNAKDM4E
SCHEMBL9449512 0.75 ACP3 (0.58) CYP2C19ALOX15TSHRSMN1; SMN2
SCHEMBL14075846 0.75 MEN1 (0.55) POLBMAPTALDH1A1LMNAKDM4E
SCHEMBL2281034 0.74 POLB (0.68) POLBMAPTALDH1A1LMNAKDM4E
SCHEMBL7160912 0.74 POLB (0.68) POLBMAPTALDH1A1LMNAKDM4E
SCHEMBL9448849 0.74 POLB (0.58) POLBMAPTALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7638505-B2 Organophosphoric derivatives useful as anti-parasitic agents UNIVERSITEIT GENT (BE) 2009-12-29 US disclosed
US-20080312190-A1 Such as 3-(N-hydroxyacetamido)-1-(3,4-dichlorophenyl)propylphosphonic acid; Antimalaria agents UNIVERSITEIT GENT (BE) 2008-12-18 US disclosed
EP-1963344-A1 ORGANOPHOSPHORIC DERIVATIVES USEFUL AS ANTI-PARASITIC AGENTS UNIVERSITEIT GENT (BE) 2008-09-03 EP disclosed
WO-2007071453-A1 ORGANOPHOSPHORIC DERIVATIVES USEFUL AS ANTI-PARASITIC AGENTS UNIVERSITEIT GENT (BE) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312190-A1 Such as 3-(N-hydroxyacetamido)-1-(3,4-dichlorophenyl)propylphosphonic acid; Antimalaria agents SUB1, CBR1, NAT1 POLB 1824/4885MAPT 4756/4885ALDH1A1 1560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.